» Articles » PMID: 20051860

Why Do Patients with Schizophrenia Smoke?

Overview
Specialty Psychiatry
Date 2010 Jan 7
PMID 20051860
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Among the mentally ill, smoking prevalence is highest in patients with schizophrenia ( approximately 70-80%). This can impose a significant financial burden on patients, not to speak of increased smoking-related morbidity and mortality. Therefore, it is critical for clinicians to understand why patients with schizophrenia smoke in order to adapt treatment schemes. Understanding the reasons may also help to develop new drugs that target the nicotinic system in the brain as well as smoking cessation programs that are specifically designed for this particular patient population.

Recent Findings: So far, several reasons have been identified which are believed to explain tobacco consumption in patients with schizophrenia. Originally, it was widely believed that patients with schizophrenia smoke to increase hepatic clearance and to restore the dopamine blockade of certain antipsychotic drugs to diminish their side effects. However, more recently it became obvious that cigarette smoking may also be reinforcing for patients because it improves psychiatric symptoms, most notably negative and cognitive symptoms. The underlying molecular mechanisms of these nicotine effects are currently under intensive investigation.

Summary: Heavy smoking in schizophrenia cannot simply be viewed as a 'bad habit'. Rather, self-medication of clinical symptoms and side effects of antipsychotic drugs appear to play a major role.

Citing Articles

Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder.

Li Y, Zhang C, Han J, Shang Y, Chen Z, Cui G Ther Adv Psychopharmacol. 2024; 14:20451253241243290.

PMID: 38708374 PMC: 11070126. DOI: 10.1177/20451253241243290.


Smoking affects symptom improvement in schizophrenia: a prospective longitudinal study of male patients with first-episode schizophrenia.

Mu X, Wu W, Wang S, Su X, Guan H, Guan X Schizophrenia (Heidelb). 2024; 10(1):34.

PMID: 38491003 PMC: 10943037. DOI: 10.1038/s41537-024-00449-1.


Demographic, biochemical, clinical, and cognitive symptom differences between smokers and non-smokers in Chinese older male patients with chronic schizophrenia.

Li W, Yue L, Xiao S Eur Arch Psychiatry Clin Neurosci. 2024; 275(1):193-199.

PMID: 38462585 PMC: 11799016. DOI: 10.1007/s00406-024-01762-7.


Prenatal nicotine exposure during pregnancy results in adverse neurodevelopmental alterations and neurobehavioral deficits.

Wells A, Lotfipour S Adv Drug Alcohol Res. 2024; 3:11628.

PMID: 38389806 PMC: 10880762. DOI: 10.3389/adar.2023.11628.


Antipsychotics and Mortality in Adult and Geriatric Patients with Schizophrenia.

Yeh L, Lee W, Kuo K, Pan Y Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256894 PMC: 10819180. DOI: 10.3390/ph17010061.